MolNFT v1 · #160319 · protein
Mtsl labelled T4 lysozyme pseudo-wild type K65C mutant
6PGY · Endolysin: “Mtsl labelled T4 lysozyme pseudo-wild type K65C mutant”. X-ray diffraction, 2 ligands (MTN, CL), 1 pocket (best druggability 0.52). MolNFT v1 #160319 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 6PGY
- Type
- protein
- Length
- 162 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Endolysin
- EC
- 3.2.1.17
- UniProt
- D9IEF7
- Ligands
- MTN, CL
- Pockets
- 1 · best druggability 0.52
Structure
x-ray diffraction · 1 distinct chain · 66% helix, 9% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Endolysin (EC 3.2.1.17) | protein | 162 | 66% helix, 9% strand | D9IEF7 |
Ligands and binding sites
- MTN · S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate · ligand · chains A
- CL · Chloride ion · ion · 2 copies · chains A
- HED · 2-hydroxyethyl disulfide · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 249 | 0.52 | 0.75 | 31 | empty |
Modifications
Observed in the structure: 1 covalent (covalent ligand).
Compared structures
- 6PGY · MTSL labelled T4 lysozyme pseudo-wild type K65C mutant · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt D9IEF7
- Elsewhere: RCSB PDB 6PGY · PDBe 6PGY · UniProt D9IEF7
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.